Search results
Results From The WOW.Com Content Network
Ranbaxy's Malvinder Singh remained as CEO after the transaction. [11] The addition of Ranbaxy Laboratories extended Daiichi-Sankyo's operations, with the combined company worth about US$30 billion. [12] In 2009, it was reported that former Novartis Senior Vice-President Yugal Sikri would lead the Indian operations of Ranbaxy Laboratories. [13] [14]
In 2006, Advent had sold 96.7% of the company to Ranbaxy. Terapia S.A. therefore went through a brand name change, and so it became Terapia Ranbaxy. Two years later, the Japanese pharmaceutical giant Daiichi Sankyo had purchased 1/5 of the company, and so Terapia Ranbaxy became part of the giant.
Ranbaxy was way more than simply "laden with controversy" as currently stated in the introduction, and the Controversies section currently does not make it clear that the company's "whose business model was completely dependent on falsifying data in their drug applications to the FDA" (in the words of Katherine Eban's interviewer).
For premium support please call: 800-290-4726 more ways to reach us
Juan Soto just got paid. He reportedly agreed Sunday with the New York Mets on a 15-year, $765 million deal, according to multiple sources.. Soto's contract is the richest known deal in the ...
Bahasa Indonesia: Undang-Undang Republik Indonesia Nomor 50 Tahun 1957 tentang Penetapan Bagian IBW I (Jawatan Pegadaian) dari Anggaran Republik Indonesia untuk Tahun Dinas 1954 English: Law of the Republic of Indonesia Number 50 of 1957
The Pelicans led 107-98 with 7:50 left in regulation, but Jokic scored seven points in a 15-2 Denver run over a 3:41 span to give the Nuggets a 113-109 lead.
You are free: to share – to copy, distribute and transmit the work; to remix – to adapt the work; Under the following conditions: attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made.